ArticleAmerican journal of translational research2017

Inhibition of Wnt/β-catenin by anthelmintic drug niclosamide effectively targets growth, survival, and angiogenesis of retinoblastoma.

Zhi Li et al.PubMed ↗Full text ↗

No numbers read from the abstract.